Biocon Biologics to offer Serum Institute of Life Sciences 15 pc stake at US $ 4.9 billion valuation
BB will have access to 100 million doses of vaccines annually and commercialization rights of the SILS vaccine portfolio for global markets
BB will have access to 100 million doses of vaccines annually and commercialization rights of the SILS vaccine portfolio for global markets
The first lot of IPV will be supplied to the government this month as per the requirement of the Health Ministry
Packaged junk food which is a major component of unhealthy diets is responsible for more deaths worldwide than any other risk factor
The institute will provide the world’s first unique and comprehensive capability to predict, prevent, respond and to recover from future pandemics
The lab has been developed to aid surgeons to overcome the challenging learning curve to obtain laparoscopic expertise
Textiles treated with the technology have also been proven to deactivate viruses, including SARS-CoV-2 (the virus that causes COVID-19).
CRISIL Ratings has revised its outlook on the long term ratings of Krishna Institute Of Medical Sciences Limited (KIMS) to 'Positive' from 'Stable' while reaffirming the ratings at 'CRISIL AA-/CRISIL A1+'
The foundation has been working closely with the Kidwai Memorial Institute of Oncology on several projects since 2001
Serum buys 50 per cent stake in Indian joint venture of SCHOTT Kaisha
KIMS Hospitals' brand, has an aggregate bed capacity of 3,064, including over 2,500 operational beds as of March 31, 2021
Subscribe To Our Newsletter & Stay Updated